Global clinical services and medicine access platform for pharma
Clinigen operates across clinical trials, specialty pharma distribution, and regulatory affairs, serving patients and pharmaceutical companies globally. The hiring mix reveals scaling pressures in regulatory affairs and operations—critical functions for a company managing managed-access programs, comparator drugs, and unlicensed medicines across multiple territories. Active projects on regulatory due diligence, marketing authorizations, and GDP compliance underscore a business moving into new geographies and acquisition integration.
Notable leadership hires: Regulatory Affairs Director
Founded in 2010, Clinigen is a UK-based pharmaceutical services company operating across three core pillars: clinical trial services, product access and commercialisation, and pharmacovigilance. The firm specializes in unlicensed medicines, managed access programs, comparator drugs, and compassionate-use support, with particular depth in oncology. Operating across 10+ countries (Netherlands, UK, Singapore, Malaysia, Australia, Ireland, US, Germany, China, Japan), the company is structured around healthcare, operations, legal, and logistics functions, with active expansion in regulatory affairs to support new market entries and acquisition integration.
Clinigen has active recruitment across 10 countries: Netherlands, United Kingdom, Singapore, Malaysia, Australia, Ireland, United States, Germany, China, and Japan.
Clinigen uses Microsoft 365 ecosystem (Word, Excel, PowerPoint, Teams, SharePoint, Outlook), Jira, Confluence, Oracle ERP, and Power BI for enterprise reporting and collaboration.
Clinigen provides clinical trial services, specialty pharmaceutical distribution, unlicensed medicines access, managed-access programs, comparator drugs, pharmacovigilance, and regulatory affairs support—with specific expertise in oncology and compassionate-use pathways.
Other companies in the same industry, closest in size